Cargando…

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats

OBJECTIVE: The prostacyclin analog, beraprost sodium (BPS), was examined for its potential to improve the symptoms of obesity-type diabetes (i.e., hyperglycemia, hyperinsulinemia, dyslipidemia, histopathologic changes, and diabetic complications). RESEARCH DESIGN AND METHODS: Obese Zucker rats, an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Nahoko, Kaneko, Masayuki, Tamura, Mitsutaka, Kurumatani, Hajimu
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844818/ https://www.ncbi.nlm.nih.gov/pubmed/20068136 http://dx.doi.org/10.2337/db09-1432

Ejemplares similares

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial
por: Koyama, Akio, et al.
Publicado: (2015)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease
por: Takenaka, M., et al.
Publicado: (2017)

Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF β-Smad Signal Pathway
por: Chen, Yun, et al.
Publicado: (2014)

Coenzyme A and Its Thioester Pools in Obese Zucker and Zucker Diabetic Fatty Rats
por: Chohnan, Shigeru, et al.
Publicado: (2020)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
por: Na, Ki Young, et al.
Publicado: (2013)

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats
por: Garcés-Rimón, M., et al.
Publicado: (2016)

Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination
por: Zheng, Huo-Liang, et al.
Publicado: (2021)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Insulin-Regulated Aminopeptidase Inhibition Ameliorates Metabolism in Obese Zucker Rats
por: Krskova, Katarina, et al.
Publicado: (2020)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
por: Blitek, Agnieszka, et al.
Publicado: (2022)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Subdural hematomas in pulmonary arterial hypertension patients treated with prostacyclin analogs
por: Louis, Lam, et al.
Publicado: (2012)

The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
por: Aldini, Giancarlo, et al.
Publicado: (2011)

Waves of Adipose Tissue Growth in the Genetically Obese Zucker Fatty Rat
por: MacKellar, Jennifer, et al.
Publicado: (2010)

Anti-Obesity Effects of Onion Extract in Zucker Diabetic Fatty Rats
por: Yoshinari, Orie, et al.
Publicado: (2012)

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
por: Decara, Juan M., et al.
Publicado: (2015)

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
por: Otsuki, Michio, et al.
Publicado: (2005)

Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2022)

Correction: Waves of Adipose Tissue Growth in the Genetically Obese Zucker Fatty Rat
por: MacKellar, Jennifer, et al.
Publicado: (2010)

Expression of fourteen novel obesity-related genes in zucker diabetic fatty rats
por: Schmid, Peter M, et al.
Publicado: (2012)

Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2019)

Beraprost and Overall Survival in Cats with Chronic Kidney Disease
por: Ito, Hiroyuki, et al.
Publicado: (2023)

Cardiovascular Characteristics of Zucker Fatty Diabetes Mellitus Rats, an Animal Model for Obesity and Type 2 Diabetes
por: Otani, Kosuke, et al.
Publicado: (2022)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
por: Wang, Pengwei, et al.
Publicado: (2022)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

Beraprost sodium attenuates the development of myocardial fibrosis after myocardial infarction by regulating GSK‐3β expression in rats
por: Li, Xing‐Xing, et al.
Publicado: (2023)

Comparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension: A Network Meta-Analysis
por: Zhang, Huijun, et al.
Publicado: (2016)

Long segment ileal transposition leads to early amelioration of glucose control in the diabetic obese Zucker rat
por: Grueneberger, Jodok Matthias, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ttcob5hf0lildbsrik2s7143hq